HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
about
The implication and potential applications of high-mobility group box 1 protein in breast cancerUntil Death Do Us Part: Necrosis and Oxidation Promote the Tumor MicroenvironmentPotential role of High mobility group box 1 in hepatocellular carcinomaInflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin.Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes.HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cellsHMGB1 in health and disease.T cells contribute to stroke-induced lymphopenia in rats.The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis.Trypanosoma cruzi High Mobility Group B (TcHMGB) can act as an inflammatory mediator on mammalian cellsLife after death: targeting high mobility group box 1 in emergent cancer therapies.Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro.Targeting HMGB1 in the treatment of sepsisHMGB1 is an early and critical mediator in an animal model of uveitis induced by IRBP-specific T cells.RAGE regulation and signaling in inflammation and beyond.HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells.Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.The Measure of DAMPs and a role for S100A8 in recruiting suppressor cells in breast cancer lung metastasis.Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjӧgren's syndrome.Hmgb1-IL-23-IL-17-IL-6-Stat3 axis promotes tumor growth in murine models of melanoma.The role of toll-like receptor 4 in tumor microenvironment.Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment.HMGB1: The Central Cytokine for All Lymphoid Cells.Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model.Post-traumatic immunosuppression is reversed by anti-coagulated salvaged blood transfusion: deductions from studying immune status after knee arthroplasty.
P2860
Q26744069-9879107E-DE1B-4685-AF80-1E6A99789FE3Q26745898-D66D2E85-A23A-494A-AB89-29B38CDE2573Q26864508-3B93AF44-3535-4AC5-B006-E04122B84249Q33685899-6F0A4D26-E20D-4D99-8809-F1919AA80E69Q33918856-CE36AA34-A2A1-4B57-8B6D-0D6230CB78FAQ34353413-0AF083C9-8240-4616-BB40-517F26731161Q34622835-63FA089E-0756-472D-A249-A06A022AB5ABQ34649287-4B47F191-B24C-42DF-984D-AD503114A1D2Q35705833-9AA271C8-8A86-487D-9388-3EFDCFBBD55AQ36274054-1AF620FA-59A7-49E5-BC92-18B3825A52A1Q36562901-4883AFD5-0670-430F-A44C-C4AEEC9A7A4BQ36985164-F5D3E63F-33F3-41E7-86F3-434613A41C61Q36997263-014FDE6F-C921-4FF1-8042-836AA1F293EAQ37622744-EB682A98-60FF-45D8-91AB-EE3150C9ECBBQ37644976-C6F69963-8FFF-4F69-B9D0-5B0D85A1F633Q38094691-5DE7A29A-077F-4E25-BEEB-06C597F5B4F4Q38930365-2E1728C5-3977-4E0A-96C5-35BC72E66D0AQ38950436-4199B7DE-48D7-4595-BF59-C06B5BF00D57Q38953395-6AB4ED00-35AC-4754-B67E-E2DD6C674BDEQ41512074-86256421-99C4-445D-B536-9B9986F4B65FQ41866168-FDB5D015-EC30-4005-A6D1-79A93C49AC6EQ42371680-7FC418D2-CD25-4E85-A12B-76CCBD54ECB3Q43185293-589A7D96-C72D-4843-A10F-CFEA66502962Q43224085-6AB4812A-FDB4-4223-845A-0C6D4F1F9DCAQ47861377-D915C841-AE6D-4471-936D-78306DDEA774Q50109080-51B5739F-20AC-4BA2-8301-6BB861C061BFQ50669220-24350AD0-FC6A-45BB-A615-A79FFCC624FC
P2860
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
description
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im August 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2012/08/01)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd op 2012/08/01)
@nl
наукова стаття, опублікована в серпні 2012
@uk
مقالة علمية (نشرت في أغسطس 2012)
@ar
name
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@ast
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@en
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@nl
type
label
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@ast
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@en
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@nl
prefLabel
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@ast
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@en
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@nl
P2093
P2860
P921
P356
P1476
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
@en
P2093
Astrid Westendorf
Christoph Bergmann
Clarissa Anni Wild
Günter Fritz
Patrick Schuler
Ramin Lotfi
Stephan Lang
Sven Brandau
Thomas K. Hoffmann
P2860
P304
P356
10.1093/INTIMM/DXS051
P577
2012-08-01T00:00:00Z